Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin

Radoslław Zagozdzon, Jakub GolŁab, Tomasz StoklŁosa, Adam Giermasz, Dorota Nowicka, Wojciech Feleszko, Witold Lasek, Marek Jakóbisiak

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin'. Together they form a unique fingerprint.

Medicine & Life Sciences